# Early treatment with metformin during acute COVID-19 linked to lower long COVID risk

**Category:** Health
**Source:** [https://www.news-medical.net](https://www.news-medical.net)
**Publisher:** News-Medical.net
**Published:** 2026-02-02
**Scraped (UTC):** 2026-02-03T18:57:53+00:00

![Article Image](https://www.news-medical.net/themes/Standard/images/full_site_logo.png)

## Summary
Early treatment with the diabetes drug metformin during acute COVID-19 infection was associated with a substantially lower risk of developing clinician-diagnosed long COVID. Evidence from trials shows it is safe, low-cost, and most effective when started soon after symptom onset.

## Full Article
A common diabetes drug may prevent long COVID when taken early

Early treatment with the diabetes drug metformin during acute COVID-19 infection was associated with a substantially lower risk of developing clinician-diagnosed long COVID. Evidence from randomized trials and real-world analyses suggests metformin is safe, low-cost, and most effective when started soon after symptom onset.

---

*Content scraped from public sources with attribution. Users assume all risk.*  
*Auto-generated by [Perplexity News Tracker](https://github.com/myidkd1-coder/perplexity-news-tracker)*